Bismuth subcitrate potassium

A02BX05(WHO) Bismuth(3+) potassium 2-olato-1,2,3-propanetricarboxylate (1:5:2) 880149-29-1 91667825 DB09275 34989447 BQE6KE1T4H D09739 Interactive image C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])[O-].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-‍‍‍‍‍‍​​​‍​​​​​​])[O-].[K+].[K+].[K+].[K+].[K+].[Bi+3] InChI=1S/2C6H7O7.Bi.5K/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;;;;/h2*1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;;;/q2*-1;+3;5*+1/p-6Key:YDDTTXDPCSCLKY-UHFFFAOYSA-H Bismuth subcitrate potassiumis abismuthsalt used in combination with antibiotics and aproton pump inhibitorfor the treatment ofHelicobacter pyloriinfections. A fixed-dose combination with the antibioticsmetronidazoleandtetracyclineis sold under the trade namePylera.